908 Devices (NASDAQ:MASS) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of 908 Devices (NASDAQ:MASS) from a hold rating to a buy rating in a report published on Saturday.

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of 908 Devices in a report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $12.00.

908 Devices Price Performance

Shares of MASS stock opened at $6.09 on Friday. The firm has a market cap of $227.64 million, a P/E ratio of 11.07 and a beta of 0.47. 908 Devices has a 1-year low of $3.55 and a 1-year high of $9.34. The firm has a fifty day moving average of $6.33 and a two-hundred day moving average of $6.64.

908 Devices (NASDAQ:MASS) last issued its earnings results on Tuesday, March 3rd. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.01. 908 Devices had a net margin of 34.68% and a negative return on equity of 14.99%. The business had revenue of $17.38 million for the quarter, compared to analyst estimates of $16.19 million. On average, sell-side analysts expect that 908 Devices will post -1.99 EPS for the current year.

Insider Buying and Selling at 908 Devices

In related news, CFO Joseph H. Iv Griffith sold 23,175 shares of the business’s stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $6.18, for a total transaction of $143,221.50. Following the completion of the sale, the chief financial officer owned 139,896 shares of the company’s stock, valued at $864,557.28. This represents a 14.21% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 23.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On 908 Devices

Large investors have recently bought and sold shares of the business. Farther Finance Advisors LLC acquired a new position in 908 Devices in the third quarter valued at approximately $28,000. Raymond James Financial Inc. acquired a new stake in shares of 908 Devices during the 2nd quarter worth approximately $48,000. Daiwa Securities Group Inc. bought a new stake in shares of 908 Devices in the 2nd quarter worth approximately $61,000. PCM Encore LLC bought a new stake in shares of 908 Devices in the 4th quarter worth approximately $62,000. Finally, The Manufacturers Life Insurance Company bought a new stake in shares of 908 Devices in the 2nd quarter worth approximately $77,000. Institutional investors own 88.06% of the company’s stock.

908 Devices Company Profile

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.